ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 9 filers reported holding ACASTI PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,361,000 | +29.6% | 1,779,882 | 0.0% | 0.09% | -4.4% |
| Q3 2019 | $3,364,000 | +65.8% | 1,779,882 | 0.0% | 0.09% | +93.6% |
| Q2 2019 | $2,029,000 | +11.8% | 1,779,882 | 0.0% | 0.05% | -7.8% |
| Q1 2019 | $1,815,000 | +22.6% | 1,779,882 | 0.0% | 0.05% | -8.9% |
| Q4 2018 | $1,480,000 | +1165.0% | 1,779,882 | +761.2% | 0.06% | +1766.7% |
| Q2 2018 | $117,000 | -38.4% | 206,677 | +10.8% | 0.00% | -40.0% |
| Q1 2018 | $190,000 | +8.0% | 186,559 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $176,000 | -67.0% | 186,559 | -50.0% | 0.01% | -40.0% |
| Q3 2017 | $534,000 | +116.2% | 373,118 | +100.0% | 0.01% | -16.7% |
| Q2 2017 | $247,000 | -2.8% | 186,559 | 0.0% | 0.01% | -14.3% |
| Q1 2017 | $254,000 | +9.0% | 186,559 | 0.0% | 0.01% | -17.6% |
| Q4 2016 | $233,000 | -43.7% | 186,559 | -21.1% | 0.02% | -37.0% |
| Q3 2016 | $414,000 | +23.2% | 236,559 | 0.0% | 0.03% | +17.4% |
| Q2 2016 | $336,000 | -6.7% | 236,559 | 0.0% | 0.02% | -28.1% |
| Q1 2016 | $360,000 | -39.4% | 236,559 | 0.0% | 0.03% | -27.3% |
| Q4 2015 | $594,000 | – | 236,559 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 236,559 | $594,000 | 0.04% |
| INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $287,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 210,484 | $537,000 | 0.00% |
| DEUTSCHE BANK AG\ | 215 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| MORGAN STANLEY | 18 | $0 | 0.00% |
| Renaissance Technologies | 20,900 | $53,000 | 0.00% |
| ROYAL BANK OF CANADA | 588 | $1,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 400 | $1,000 | 0.00% |